Banyan Biomarkers, Inc. Company Profile

06:44 EDT 23rd March 2019 | BioPortfolio

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head injured patients. Banyan Biomarkers has a licensing agreement with the University of Florida for exclusive global use of technology related to this product. To learn more about Banyan Biomarkers, Inc., visit

News Articles [298 Associated News Articles listed on BioPortfolio]

Banyan Biomarkers Receives Contract by U.S. Department of Defense for Banyan BTI™

Banyan Biomarkers, Inc., a pioneer in developing biomarkers for mild traumatic brain injury (TBI), has been awarded a contract by the U.S. Department of Defense (DOD) to pr...

Banyan Biomarkers Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06092018] Prices from USD $750

SummaryBanyan Biomarkers Inc Banyan Biomarkers is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The com...

Banyan Biomarkers Inc Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryBanyan Biomarkers Inc Banyan Biomarkers is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The com...

Biomarkers Congress

February 21-22, 2019 Manchester, U.K. The post Biomarkers Congress appeared first on GEN - Genetic Engineering and Biotechnology News.

Better Biomarkers Could Help Us Treat Alzheimer's

We need better molecular biomarkers to create targeted drugs -- Read more on

Global EPO Biomarkers Market Research and Forecast 2018-2023 – The Upcoming Patent Expiration of EPO Biomarkers is Driving Growth –

DUBLIN–(BUSINESS WIRE)–The “Global EPO Biomarkers Market Research and Forecast 2018-2023” report has been added to’s offering. Major factors contri...

Betting Combos on Biomarkers

Drug developers are charging forward with immunotherapy combinations based on yet-to-be-validated biomarkers, despite lack of efficacy as monotherapy.

Serum and CSF Biomarkers of Brain Injury After Sports-related Concussion

ABSTRACT & COMMENTARY: So far none of the currently measured biomarkers has sufficient sensitivity or specificity to be clinically useful.

Drugs and Medications [0 Results]


PubMed Articles [845 Associated PubMed Articles listed on BioPortfolio]

PanelomiX for the Combination of Biomarkers.

Proteomics has allowed the discovery and validation of a massive number of biomarkers. However most of them suffer from insufficient specificity and sensitivity and therefore didn't translate to clini...

Age-dependent co-dependency structure of biomarkers in the general population of the United States.

Phenotypic biomarkers (e.g. cholesterol, weight, and glucose) are important to diagnose and treat diseases associated with aging. However, while many biomarkers are co-dependent (e.g. glycohemoglobin ...

Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.

Recent advances in targeted therapies have raised expectations that the clinical application of biomarkers would improve patient's health outcomes and potentially save costs. However, the cost-effecti...

Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.

Sepsis management guidelines endorse use of biomarkers to support clinical assessment and treatment decisions in septic patients. The impact of biomarkers on improving patient outcomes remains uncerta...

Biomarkers for diagnosis of childhood tuberculosis: A systematic review.

As studies of biomarkers of tuberculosis (TB) disease provide hope for a simple, point-of-care test, we aimed to synthesize evidence on biomarkers for diagnosis of TB in children and compare their acc...

Clinical Trials [2235 Associated Clinical Trials listed on BioPortfolio]

A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes

The purpose of this study is to study the biomarkers in subjects before and after sports-induced traumatic brain injury. The assay will be studied in a sample population of subjects over t...

Identification of Biomarkers for Severe Pneumonia

To identify the potential serum biomarkers with regard to the severity of pneumonia, and to further evaluate the prognostic value of these markers.

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions

The purpose of this study is to prospectively asses established biomarkers in the diagnosis and prognosis of patients and will include assessment of a number of biomarkers, genomics and pr...

ADDIA Chronobiological Study

The present single center clinical chronobiological study on 24 subjects (12 patients with mild to moderate form of Alzheimer's disease and 12 Healthy subjects) aims at characterizing the ...

Defining the Skin and Blood Biomarkers of Ichthyosis

Ichthyosis is a group of genetic skin disorders that present with dry, thickened, scaly, or flaky skin. As of today, there is no cure or treatment. Doctors can only treat the dry skin with...

Companies [151 Associated Companies listed on BioPortfolio]

Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focus...

Banyan Finance, LLC

Founded in 2007, Banyan Finance is the leading resource in the Casualty Medical Plan segment for physicians and other medical service providers. As an issuer of Casualty Medical P...

Amplion Inc.

Amplion publishes BiomarkerBase™ (, the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every ...


We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Vali...


NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and ...

More Information about "Banyan Biomarkers, Inc." on BioPortfolio

We have published hundreds of Banyan Biomarkers, Inc. news stories on BioPortfolio along with dozens of Banyan Biomarkers, Inc. Clinical Trials and PubMed Articles about Banyan Biomarkers, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Banyan Biomarkers, Inc. Companies in our database. You can also find out about relevant Banyan Biomarkers, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record